In vitro selection of Neisseria gonorrhoeae mutants with elevated MIC values and increased resistance to cephalosporins

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 11, 2014, Pages 6986-6989

  Johnson, Steven R ^a   Grad, Yonatan ^c,d   Ganakammal, Satishkumar Ranganathan ^b   Burroughs, Mark ^a,b   Frace, Mike ^b   Lipsitch, Marc ^c   Weil, Ryan ^b   Trees, David ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFIXIME; CEFPODOXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; ERYTHROMYCIN; GAMMA GLUTAMYLTRANSFERASE; PENICILLIN DERIVATIVE; TETRACYCLINE; ANTIINFECTIVE AGENT; BETA LACTAMASE; FIMBRIA PROTEIN; PENICILLIN BINDING PROTEIN; PILQ PROTEIN, BACTERIA;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM ISOLATION; BACTERIUM MUTANT; GENE INSERTION; IN VITRO SELECTION; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; NONHUMAN; NUCLEOTIDE SEQUENCE; PENA GENE; PILQ GENE; POINT MUTATION; DRUG EFFECTS; GENETICS; GONORRHEA; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOLECULAR GENETICS; MULTIDRUG RESISTANCE; MUTATION; TREATMENT FAILURE;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CEPHALOSPORINS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ERYTHROMYCIN; FIMBRIAE PROTEINS; GONORRHEA; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTATION; NEISSERIA GONORRHOEAE; PENICILLIN-BINDING PROTEINS; TREATMENT FAILURE;

EID: 84908430626     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.03082-14     Document Type: Article

References (35)

1. Lo JYC, Ho KM, Leung AOC, Tiu FST, Tsang GKL, Lo ACT, Tapsall JW. 2008. Ceftibuten resistance and treatment failure of Neisseria gonorrhoeae infection. Antimicrob. Agents Chemother. 52:3564-3567. http://dx.doi.org/10.1128/AAC.00198-08.
2. Tapsall J. 2006. Antibiotic resistance in Neisseria gonorrhoeae is diminishing available treatment options for gonorrhea: some possible remedies. Expert Rev. Anti Infect. Ther. 4:619-628. http://dx.doi.org/10.1586/14787210.4.4.619.
3. Tapsall JW, Ndowa F, Lewis DA, Unemo M. 2009. Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae. Expert Rev. Anti Infect. Ther. 7:821-834. http://dx.doi.org/10.1586/eri.09.63.
4. Tapsall J, Read P, Carmody C, Bourne C, Ray S, Limnios A, Sloots T, Wiley J. 2009. Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoeae verified by molecular microbiological methods. J. Med. Microbiol. 58:683-687. http://dx.doi.org/10.1099/jmm.0.007641-0.
5. Ohnishi M, Goliparian D, Shimuta K, Saiki T, Hoshina S, Iwasaku K, Nakayama S, Kitikawa J, Unemo M. 2011. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea? Characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob. Agents Chemother. 55:3538-3545. http://dx.doi.org/10.1128/AAC.00325-11.
6. Unemo M, Goliparian D, Nicholas RA, Ohnishi M, Gallay A, Sednaoui P. 2012. High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antmicrob. Agents Chemother. 56:1273-1280. http://dx.doi.org/10.1128/AAC.05760-11.
7. Brannigan JA, Tirodimos IA, Zhang Q-Y, Dowson CG, Spratt BG. 1990. Insertion of an extra amino acid is the main cause of the low affinity of penicillin-binding protein 2 in penicillin-resistant strains of Neisseria gonorrhoeae. Mol. Microbiol. 4:913-919. http://dx.doi.org/10.1111/j.1365-2958.1990.tb00664.x.
8. Lee S-G, Lee H, Jeong SH, Yong D, Chung GT, Lee YS, Chong Y, Lee K. 2010. Various penA mutations together with mtrR, porB, and ponA mutations in Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime or ceftriaxone. J. Antimicrob. Chemother. 65:669-675. http://dx.doi.org/10.1093/jac/dkp505.
9. Ropp PA, Nicholas RA. 1997. Cloning and characterization of the ponA gene encoding penicillin-binding protein 1 from Neisseria gonorrhoeae and Neisseria meningitides. J. Bacteriol. 179:2783-2787.
10. Ropp PA, Hu M, Olesky M, Nicholas RA. 2002. Mutations in ponA, the gene encoding penicillin-binding protein 1 and a novel locus, penC, are required for high-level chromosomally mediated penicillin resistance in Neisseria gonorrhoeae. Antimicrob. Agents Chemother. 46:769-777. http://dx.doi.org/10.1128/AAC.46.3.769-777.2002.
11. Folster JP, Dhulipala V, Nicholas RA, Shafer WM. 2007. Differential regulation of ponA and pilMNOPQ expression by the MtrR transcriptional regulatory protein in Neisseria gonorrhoeae. J. Bacteriol. 189:4569-4577. http://dx.doi.org/10.1128/JB.00286-07.
12. Hagman KE, Pan W, Spratt BG, Balthazar JT, Judd RC, Shafer WM. 1995. Resistance of Neisseria gonorrhoeae to hydrophobic agents is modulated by the mtrRCDE efflux system. Microbiology 141:611-622. http://dx.doi.org/10.1099/13500872-141-3-611.
13. Veal WL, Nicholas RA, Shafer WM. 2002. Overexpression of the MtrC-MtrD-MtrE efflux pump due to an mtrR mutation is required for chromosomally mediated penicillin resistance in Neisseria gonorrhoeae. J. Bacteriol. 184:5619-5624. http://dx.doi.org/10.1128/JB.184.20.5619-5624.2002.
14. Olesky M, Hobbs M, Nicholas RA. 2002. Identification and analysis of amino acid mutations in porin IB that mediate intermediate-level resistance to penicillin and tetracycline in Neisseria gonorrhoeae. Antimicrob. Agents Chemother. 46:2811-2820. http://dx.doi.org/10.1128/AAC.46.9.2811-2820.2002.
15. Gill MJ, Simjee S, Al-Hatawi K, Robertson BD, Easmon CSF, Ison CA. 1998. Gonococcal resistance to beta-lactams and tetracycline involves mutation in loop 3 of the porin encoded at the penB locus. Antmicrob. Agents Chemother. 42:2799-2803.
16. Ameyama S, Onodera S, Takahata M, Minami S, Maki N, Endo K, Goto H, Suzuki H, Oishi Y. 2002. Mosaic-like structure of penicillin-binding protein 2 gene (penA) in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime. Antimicrob. Agents Chemother. 46:3744-3749. http://dx.doi.org/10.1128/AAC.46.12.3744-3749.2002.
17. Lindberg R, Fredlund H, Nicholas RA, Unemo M. 2007. Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porBIb, and ponA. Antimicrob. Agents Chemother. 51:2117-2122. http://dx.doi.org/10.1128/AAC.01604-06.
18. Ito M, Deguchi T, Mizutani KS, Yasuda M, Yokoi S, Ito S-I, Takahashi Y, Ishihara S, Kawamura Y, Ezaki T. 2005. Emergence and spread of Neisseria gonorrhoeae clinical isolates harboring mosaic-like structure of penicillin-binding protein 2 in central Japan. Antimicrob. Agents Chemother. 49:137-143. http://dx.doi.org/10.1128/AAC.49.1.137-143.2005.
19. Spratt BG, Bowler LD, Zhang QY, Zhou J, Smith JM. 1992. Role of interspecies transfer of chromosomal genes in the evolution of penicillin resistance in pathogenic and commensal Neisseria species. J. Mol. Evol. 34:115-125.
20. Johnson SR, Sandul AL, Parehk M, Wang SA, Knapp JS, Trees DL. 2003. Mutations causing in vitro resistance to azithromycin in Neisseria gonorrhoeae. Int. J. Antimicrob. Agents 21:414-419. http://dx.doi.org/10.1016/S0924-8579(03)00039-6.
21. Johnson SR, Steiner BM, Perkins GH. 1996. Cloning and characterization of the catalase gene of Neisseria gonorrhoeae: use of the gonococcus as a host organism for recombinant DNA. Infect. Immun. 64:2627-2634.
22. Fisher S, Barry A, Abreu J, Minie B, Nolan J, Delory TM, Young G, Fennell TJ, Allen A, Ambroglio L, Berlin AM, Blumenstiel B, Cibulskis K, Friedrich D, Johnson R, Juhn F, Reilly B, Shammas R, Stalker J, Sykes SM, Thompson J, Walsh J, Zimmer A, Zwirko Z, Gabriel S, Nicol R, Nusbaum C. 2011. A scalable, fully automated process for construction of sequence-ready human exome targeted capture libraries. Genome Biol. 12:R1. http://dx.doi.org/10.1186/gb-2011-12-1-r1.
23. Li H, Durbin R. 2009. Fast and accurate short read alignments with Burrows-Wheeler transform. Bioinformatics 25:1754-1760. http://dx.doi.org/10.1093/bioinformatics/btp324.
24. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R. 2009. The sequence alignment/map format and SAMtools. Bioinformatics 25: 2078-2079. http://dx.doi.org/10.1093/bioinformatics/btp352.
25. Blankenberg D, von Kuster G, Coraor N, Ananda G, Lazerus R, Mangan M, Nekrutenko A, Taylor J. 2010. Galaxy: a web-based genome analysis tool for experimentalists. Curr. Protoc. Mol. Biol. Chapter 19: Unit 19.10.1-21. http://dx.doi.org/10.1002/0471142727.mb1910s89.
26. Giardine B, Riemer C, Hardison RC, Burhans R, Elnitski L, Shah P, Zhang Y, Blankenberg D, Albert I, Taylor J, Miller W, Kent WJ, Nekrutenko A. 2005. Galaxy: a platform for interactive large-scale genome analysis. Genome Res. 15:1451-1455. http://dx.doi.org/10.1101/gr.4086505.
27. Goecks J, Nekrutenko A, Taylor J. 2010. Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences. Genome Biol. 11:R86. http://dx.doi.org/10.1186/gb-2010-11-8-r86.
28. Galtier N, Gouy M, Carter C. 1996. SEAVIEW and PHYLO-Win: two graphic tools for sequence alignment and molecular phylogeny. Comput. Appl. Biosci. 12:543-548.
29. Gouy M, Guindon S, Gascuel O. 2010. SEAVIEW version 4: a multiplatform graphical user interface for sequence alignment and phylogenetic tree building. Mol. Biol. Evol. 27:221-224. http://dx.doi.org/10.1093/molbev/msp259.
30. Tomberg J, Unemo M, Ohnishi M, Davies C, Nicholas RA. 2013. Identification of amino acids conferring high-level resistance to cephalosporins in the penA gene from Neisseria gonrrhoeae strain H041. Antimicrob. Agents Chemother. 57:3029-3036. http://dx.doi.org/10.1128/AAC.00093-13.
31. Chen CJ, Tobiason DM, Thomas CE, Shafer WM, Seifert HS, Sparling PF. 2004. A mutant form of the Neisseria gonorrhoeae pilus secretin protein PilQ allows increased entry of heme and antimicrobial compounds. J. Bacteriol. 186:730-739. http://dx.doi.org/10.1128/JB.186.3.730-739.2004.
32. Zhao S, Tobiason DM, Hu M, Seifert HS, Nicholas RA. 2005. The penC mutation conferring antibiotic resistance in Neisseria gonorrhoeae arises from a mutation in the PilQ secretin that interferes with multimer stability. Mol. Microbiol. 57:1238-1251. http://dx.doi.org/10.1111/j.1365-2958.2005.04752.x.
33. Kellogg DS, Jr, Cohen IR, Norins LC, Schroeter AL, Reising G. 1968. Neisseria gonorrhoeae. II. Colonial variation and pathogenicity during 35 months in vitro. J. Bacteriol. 96:596-605.
34. Kellogg DS, Peacock WL, Deacon WE, Browh L, Perkle CI. 1963. Neisseria gonorrhoeae. I. Virulence linked to colonial variation. J. Bacteriol. 85:1274-1279.
35. Helm RA, Barnhart MM, Seifert HS. 2007. pilQ missense mutations have diverse effects on PilQ multimer formation, piliation and pilus function in Neisseria gonorrhoeae. J. Bacteriol. 189:3198-3207. http://dx.doi.org/10.1128/JB.01833-06.